Impact Biomedical IBO
NYSE IBO
$0.48 +0.03 (+6.83%)
As of: Aug 21, 2026 · 2:19 PM EDT

Impact Biomedical (IBO) Shares Outstanding (Entity) (2022 - 2026)

Impact Biomedical (IBO) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.54 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.73 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 252.88 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 575.47 Mn
10 Impact Biomedical 49.54 Mn 49.53 Mn 2,000.00 107.82 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 107.82 Mn
Mar 31, 2026 107.82 Mn
Dec 31, 2025 31.55 Mn
Sep 30, 2025 12.19 Mn
Jun 30, 2025 12.19 Mn
Mar 31, 2025 12.06 Mn
Dec 31, 2024 10.76 Mn
Sep 30, 2024 60.50 Mn
Jun 30, 2024 10.00 Mn
Mar 31, 2024 10.00 Mn
Dec 31, 2023 60.50 Mn
Sep 30, 2023 70.50 Mn
Jun 30, 2023 70.49 Mn
Mar 31, 2023 70.50 Mn
Dec 31, 2022 70.49 Mn
Sep 30, 2022 70.50 Mn
Jun 30, 2022 70.49 Mn